Journal article
Predictors, Prognosis, and Management of New Clinically Important Atrial Fibrillation After Noncardiac Surgery
Abstract
(Abstracted from Anesth Analg, 125(1):162–169, 2017) The purpose of the POISE (PeriOperative ISchemic Evaluation) trial substudy has multiple objectives: it aims to deduce the associations between new clinically important atrial fibrillation (AF) and patient outcomes, as well as patient management strategies, while identifying a valid clinical prediction model for new clinically important AF in patients undergoing noncardiac surgery.
Authors
Alonso-Coello P; Cook D; Xu SC; Sigamani A; Berwanger O; Sivakumaran S; Yang H; Xavier D; Martinez LX; Ibarra P
Journal
Survey of Anesthesiology, Vol. 61, No. 5-6,
Publisher
Wolters Kluwer
Publication Date
2017
DOI
10.1097/01.sa.0000527545.40789.1d
ISSN
0039-6206